Enhancing Efficiency in Early-Phase Oncology Trials: Strategies for Accelerating Data Flow

In clinical oncology research, the velocity of data flow is of paramount importance, particularly in early-phase trials. Sponsors depend on data to assess treatment toxicities and to safeguard patient safety. An uninterrupted flow of data enables timely decision-making to address clinical trial challenges quickly and effectively. Further, strong and verified clinical data can bolster sponsors’ fundraising and deal-making endeavors, ultimately advancing the pace of discovery and innovation in cancer treatment.

Early-phase oncology trials often encounter unique challenges that create data flow bottlenecks such as the gated patient enrollment, post-pandemic resource constraints that are commonly witnessed at research sites and overcomplicated electronic case report form (eCRF) design. The lack of timely data flow can lead to numerous challenges that impact the lifecycle of data within a trial.

Implementing enhanced data flow strategies, including improved cohort management planning, site support and training, as well as careful electronic data capture (EDC) system selection and testing, allows sponsors to tackle these early-phase oncology trial challenges holistically while increasing trial efficiency.

Register for this webinar today to gain insights into how you can navigate and overcome data flow challenges in early-phase oncology clinical trials.

Speakers

Bin Pan, PhD, Executive Director, Head of Hematology & Oncology, TFS HealthScience

Bin Pan has 23 years of experience in clinical research with a strong focus on early-phase oncology trial strategy and execution. She has a scientific background in biochemistry and molecular biology with postdoctoral research in cellular signaling pathways.

Throughout her career, Bin has supported numerous oncology studies through an evolving therapeutic landscape from the early days of mAb drugs such as trastuzumab and cetuximab to the current immuno-oncology revolution with checkpoint inhibitors such as CAR-T and TCR-T.

She maintains a broad knowledge of current oncology therapeutics and the competitive clinical landscape. She provides strategic guidance and operational leadership to internal cross-functional teams as well as a consultative approach to developing novel solutions.

Message Presenter

Michael Mendoza, Executive Director, eClinical Technology and Biometrics, TFS HealthScience

Michael Mendoza is a highly experienced Executive Director of Clinical Data Systems with expert global experience within the CRO and technology environments. He holds certifications in Medidata Rave and multiple EDC platforms.

In the past, he served as a Product Owner for technology (EDC, IRT) for a large organization. He enjoys active involvement in projects for clients, delivering biometric and technology services. Michael has established teams in Krakow, Poland; Mumbai and Bangalore, India; Sofia, Bulgaria; the UK; Spain; Germany; and the United States.

His extensive experience spans trials in Phases I-IV and encompasses a full spectrum of company profiles, including large pharmaceutical companies, small biotech companies and device companies. He provides expertise and specializes in clinical technologies such as RBQM, IRT, EDC, data reporting, visualizations and data integrations using web services and other APIs. Michael is passionate about solving challenges and addressing the needs of clinical trials and patients.

Message Presenter